Intellipharmaceutics International
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$2,892,394 and profit margin reached -4401%. Total operating expenses were $2,916,235.
Profit Margin
| 2013 | 1.52M | -11.49M | -752.55% |
|---|---|---|---|
| 2014 | 8.76M | -3.85M | -43.97% |
| 2015 | 4.09M | -7.43M | -181.65% |
| 2016 | 2.24M | -10.14M | -451.43% |
| 2017 | 5.50M | -8.85M | -160.91% |
| 2018 | 1.71M | -13.74M | -802.66% |
| 2019 | 3.48M | -8.08M | -232.28% |
| 2020 | 1.40M | -3.39M | -241.95% |
| 2021 | 0 | -5.14M | |
| 2022 | 65.72K | -2.89M | -4400.55% |
IPCI.TO Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 65.72K | 0 | 1.40M | 3.48M | 1.71M | 5.50M | 2.24M | 4.09M | 8.76M | 1.52M |
Cost of revenue | 0 | 0 | 0 | 33.06K | 124.87K | 704.00K | 8.16M | 7.24M | 8.02M | 5.07M |
Gross profit | 65.72K | 0 | 1.40M | 3.44M | 1.58M | 4.80M | -5.91M | -3.15M | 749.49K | -3.54M |
Operating exp. | ||||||||||
Research and development | 2.14M | 2.66M | 3.51M | 6.60M | 10.82M | 9.27M | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 39.74K | 65.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 2.91M | 4.17M | 6.07M | 11.28M | 14.91M | 13.06M | 3.93M | 3.95M | 4.28M | 3.26M |
Operating income | -2.85M | -4.17M | -4.67M | -7.83M | -13.32M | -8.26M | -9.85M | -7.11M | -3.53M | -6.81M |
Other income (expenses), net | -36.55K | -1.08M | 1.32M | -255.06K | 8.59K | -591.65K | -22.47K | -322.93K | -323.65K | -4.24M |
Income before tax | -2.88M | -5.25M | -3.35M | -8.09M | -13.74M | -8.85M | -10.14M | -7.43M | -3.85M | -11.49M |
Income tax expense | 5.33K | -114.18K | 32.83K | -5.36K | -8.59K | 80.09K | 22.47K | 67.81K | -10.89K | 4.24M |
Net income | -2.89M | -5.14M | -3.39M | -8.08M | -13.74M | -8.85M | -10.14M | -7.43M | -3.85M | -11.49M |
Earnings per share | ||||||||||
Basic EPS | -0.08 | -0.17 | -0.14 | -0.37 | -2.89 | -2.86 | -3.8 | -3.13 | -1.67 | -5.84 |
Diluted EPS | -0.08 | -0.17 | -0.14 | -0.37 | -2.89 | -2.86 | -3.8 | -3.13 | -1.67 | -5.84 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |